Pharmaceutical

EU access to oncology medicines lags behind in the Netherlands

In a report, findings suggested that cancer patients in the Netherlands will face longer waits to access new oncology medicines.

Jan 17, 2024 - 18:00
EU access to oncology medicines lags behind in the Netherlands
In a report, findings suggested that cancer patients in the Netherlands will face longer waits to access new oncology medicines.
Read the original article

Tags:

Previous Article

Avoid “narrow national interest” in fighting next pandemic, WHO chief says

Next Article

Stalica raises $17.5m to advance neurology programmes

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Biden launches a new push to limit health care costs, hoping to show he can save money for families

STAT+: Biden launches a new push to limit health care c...

Jul 10, 2023

Lantidra wins FDA approval as first-ever type 1 diabetes cell therapy

Lantidra wins FDA approval as first-ever type 1 diabete...

Jun 29, 2023

Gilead and Tentarix partner on cancer and inflammation therapies

Gilead and Tentarix partner on cancer and inflammation ...

Aug 16, 2023